Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq

Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq

Abstract Background The pathogenic mechanism of dilated cardiomyopathy (DCM) remains to be defined. This study aimed to identify hub genes and immune cells that could serve as potential therapeutic targets for DCM. Methods We downloaded four datasets from the Gene Expression Omnibus (GEO) database:...

Full description

Bibliographic Details
Main Authors: Chenggang Fang, Zhan Lv, Zhimin Yu, Kexin Wang, Chengkai Xu, Yixuan Li, Yanggan Wang
Format: Article
Language:English
Published: BMC 2022-07-01
Series:BMC Cardiovascular Disorders
Subjects:
Dilated cardiomyopathy
DCM
Hub genes
Biomarker
Immune microenvironment
Online Access:https://doi.org/10.1186/s12872-022-02759-7

Internet

https://doi.org/10.1186/s12872-022-02759-7

Similar Items